BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

266 related articles for article (PubMed ID: 23060793)

  • 1. Nicotine, Auditory Sensory Memory, and sustained Attention in a Human Ketamine Model of Schizophrenia: Moderating Influence of a Hallucinatory Trait.
    Knott V; Shah D; Millar A; McIntosh J; Fisher D; Blais C; Ilivitsky V
    Front Pharmacol; 2012; 3():172. PubMed ID: 23060793
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Interactive effects of an N-methyl-d-aspartate receptor antagonist and a nicotinic acetylcholine receptor agonist on mismatch negativity: Implications for schizophrenia.
    Hamilton HK; D'Souza DC; Ford JM; Roach BJ; Kort NS; Ahn KH; Bhakta S; Ranganathan M; Mathalon DH
    Schizophr Res; 2018 Jan; 191():87-94. PubMed ID: 28711472
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Separate and combined effects of low dose ketamine and nicotine on behavioural and neural correlates of sustained attention.
    Knott VJ; Millar AM; McIntosh JF; Shah DK; Fisher DJ; Blais CM; Ilivitsky V; Horn E
    Biol Psychol; 2011 Sep; 88(1):83-93. PubMed ID: 21742012
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Nicotine fails to attenuate ketamine-induced cognitive deficits and negative and positive symptoms in humans: implications for schizophrenia.
    D'Souza DC; Ahn K; Bhakta S; Elander J; Singh N; Nadim H; Jatlow P; Suckow RF; Pittman B; Ranganathan M
    Biol Psychiatry; 2012 Nov; 72(9):785-94. PubMed ID: 22717030
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of nicotine on the neurophysiological and behavioral effects of ketamine in humans.
    Mathalon DH; Ahn KH; Perry EB; Cho HS; Roach BJ; Blais RK; Bhakta S; Ranganathan M; Ford JM; D'Souza DC
    Front Psychiatry; 2014; 5():3. PubMed ID: 24478731
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ketamine-induced deficits in auditory and visual context-dependent processing in healthy volunteers: implications for models of cognitive deficits in schizophrenia.
    Umbricht D; Schmid L; Koller R; Vollenweider FX; Hell D; Javitt DC
    Arch Gen Psychiatry; 2000 Dec; 57(12):1139-47. PubMed ID: 11115327
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Acute separate and combined effects of cannabinoid and nicotinic receptor agonists on MMN-indexed auditory deviance detection in healthy humans.
    de la Salle S; Inyang L; Impey D; Smith D; Choueiry J; Nelson R; Heera J; Baddeley A; Ilivitsky V; Knott V
    Pharmacol Biochem Behav; 2019 Sep; 184():172739. PubMed ID: 31283908
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Modulation of auditory deviance detection by acute nicotine is baseline and deviant dependent in healthy nonsmokers: a mismatch negativity study.
    Knott V; Impey D; Philippe T; Smith D; Choueiry J; de la Salle S; Dort H
    Hum Psychopharmacol; 2014 Sep; 29(5):446-58. PubMed ID: 25196041
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Glutamatergic modulation of auditory information processing in the human brain.
    Gunduz-Bruce H; Reinhart RM; Roach BJ; Gueorguieva R; Oliver S; D'Souza DC; Ford JM; Krystal JH; Mathalon DH
    Biol Psychiatry; 2012 Jun; 71(11):969-77. PubMed ID: 22036036
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inhibition of cerebral type 1 cannabinoid receptors is associated with impaired auditory mismatch negativity generation in the ketamine model of schizophrenia.
    Roser P; Haussleiter IS; Chong HJ; Maier C; Kawohl W; Norra C; Juckel G
    Psychopharmacology (Berl); 2011 Dec; 218(4):611-20. PubMed ID: 21590281
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mismatch negativity in tobacco-naïve cannabis users and its alteration with acute nicotine administration.
    Impey D; El-Marj N; Parks A; Choueiry J; Fisher D; Knott VJ
    Pharmacol Biochem Behav; 2015 Sep; 136():73-81. PubMed ID: 26188167
    [TBL] [Abstract][Full Text] [Related]  

  • 12. NMDA Receptor Antagonist Effects on Speech-Related Mismatch Negativity and Its Underlying Oscillatory and Source Activity in Healthy Humans.
    de la Salle S; Shah D; Choueiry J; Bowers H; McIntosh J; Ilivitsky V; Knott V
    Front Pharmacol; 2019; 10():455. PubMed ID: 31139075
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Nicotine and the hallucinating brain: effects on mismatch negativity (MMN) in schizophrenia.
    Fisher DJ; Grant B; Smith DM; Borracci G; Labelle A; Knott VJ
    Psychiatry Res; 2012 Apr; 196(2-3):181-7. PubMed ID: 22425471
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Glutamatergic deficit and schizophrenia-like negative symptoms: new evidence from ketamine-induced mismatch negativity alterations in healthy male humans.
    Thiebes S; Leicht G; Curic S; Steinmann S; Polomac N; Andreou C; Eichler I; Eichler L; Zöllner C; Gallinat J; Hanganu-Opatz I; Mulert C
    J Psychiatry Neurosci; 2017 Jun; 42(4):273-283. PubMed ID: 28556775
    [TBL] [Abstract][Full Text] [Related]  

  • 15. An α7 nAChR approach for the baseline-dependent modulation of deviance detection in schizophrenia: A pilot study assessing the combined effect of CDP-choline and galantamine.
    Choueiry J; Blais CM; Shah D; Smith D; Fisher D; Labelle A; Knott V
    J Psychopharmacol; 2023 Apr; 37(4):381-395. PubMed ID: 36927273
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Nicotinic modulation of human auditory sensory memory: Evidence from mismatch negativity potentials.
    Baldeweg T; Wong D; Stephan KE
    Int J Psychophysiol; 2006 Jan; 59(1):49-58. PubMed ID: 16313986
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mismatch negativity encoding of prediction errors predicts S-ketamine-induced cognitive impairments.
    Schmidt A; Bachmann R; Kometer M; Csomor PA; Stephan KE; Seifritz E; Vollenweider FX
    Neuropsychopharmacology; 2012 Mar; 37(4):865-75. PubMed ID: 22030715
    [TBL] [Abstract][Full Text] [Related]  

  • 18. CDP-choline and galantamine, a personalized α7 nicotinic acetylcholine receptor targeted treatment for the modulation of speech MMN indexed deviance detection in healthy volunteers: a pilot study.
    Choueiry J; Blais CM; Shah D; Smith D; Fisher D; Illivitsky V; Knott V
    Psychopharmacology (Berl); 2020 Dec; 237(12):3665-3687. PubMed ID: 32851421
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Nicotinic modulation of auditory evoked potential electroencephalography in a rodent neurodevelopmental model of schizophrenia.
    Kohlhaas KL; Robb HM; Roderwald VA; Rueter LE
    Biochem Pharmacol; 2015 Oct; 97(4):482-487. PubMed ID: 26032639
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of transcranial direct current stimulation on the auditory mismatch negativity response and working memory performance in schizophrenia: a pilot study.
    Impey D; Baddeley A; Nelson R; Labelle A; Knott V
    J Neural Transm (Vienna); 2017 Nov; 124(11):1489-1501. PubMed ID: 28864916
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.